TRVN Short Information, Trevena Inc.

Twenty Trading Day Totals
Total Shorted Volume	13,286,002
Total Actual Volume	65,572,174

Averages
Average Short Volume	664,300
Average Short Percentage	50.34%

Is there a TRVN Short Squeeze or Breakout about to happen?

See the TRVN Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2021-01-22	2.15	2.21	2.22	2.12	2,683,993	414,919	37.9743
2021-01-21	2.18	2.16	2.18	2.12	1,586,598	362,464	51.2061
2021-01-20	2.19	2.15	2.2	2.12	2,196,207	569,000	56.5642
2021-01-19	2.19	2.18	2.25	2.14	3,119,217	733,415	54.3891
2021-01-15	2.19	2.12	2.24	2.11	3,480,135	783,542	59.0134
2021-01-14	2.22	2.18	2.24	2.16	2,372,629	634,462	56.3867
2021-01-13	2.22	2.2301	2.2387	2.16	2,364,063	555,719	41.2829
2021-01-12	2.21	2.21	2.24	2.15	2,864,215	547,469	41.0028
2021-01-11	2.33	2.18	2.34	2.16	5,115,043	1,222,936	52.9886
2021-01-08	2.42	2.4	2.47	2.38	2,991,652	624,094	46.1455
2021-01-07	2.24	2.42	2.42	2.24	4,288,837	662,390	35.5867
2021-01-06	2.1731	2.22	2.31	2.17	3,914,795	812,182	54.4677
2021-01-05	2.09	2.16	2.18	2.065	2,261,318	508,514	48.6436
2021-01-04	2.12	2.11	2.15	2.06	3,716,964	654,124	41.6193
2020-12-31	2.15	2.14	2.175	2.08	3,421,691	838,776	62.4701
2020-12-30	2.13	2.14	2.2	2.09	2,056,702	471,361	51.1066
2020-12-29	2.2	2.13	2.22	2.1	3,703,524	864,212	66.2252
2020-12-28	2.29	2.2	2.33	2.2	3,473,908	674,647	54.1561
2020-12-24	2.47	2.29	2.495	2.28	2,934,044	742,436	59.5452
2020-12-23	2.39	2.46	2.52	2.385	7,026,639	609,340	36.0038

Stock Information

Trevena Inc. Company Name:

TRVN Stock Symbol:

NASDAQ Market:

Trevena Inc. Website:

TRVN Short Information, Trevena Inc.

Get TRVN Alerts

News, Short Squeeze, Breakout and More Instantly...

TRVN - Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences

CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate ...
TRVN - Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK(TM) and Announces Anticipated Pipeline Catalysts

-- Build-out of customer-facing team on track for this quarter OLINVYK comprehensive product dossier / health economic model now available to facilitate formulary reviews -- CHESTERBROOK, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a b...
TRVN - Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting

-- P resentations highlight efficacy of TRV045 in animal models of neuropathic pain and epilepsy TRV045 selectively targets the S1P 1 receptor without associated lymphopenia IND filing on track for 1H 2021 -- CHESTERBROOK...